STOML3 inhibitors are a class of chemical compounds that specifically target and inhibit the function of STOML3 (Stomatin-like protein 3), a member of the stomatin-domain family. STOML3 is involved in regulating the mechanosensitivity of ion channels, particularly in sensory neurons, where it plays a role in the modulation of mechanotransduction. This process allows cells to convert mechanical stimuli, such as touch or pressure, into electrical signals. STOML3 is known to interact with mechanosensitive ion channels, such as Piezo channels, and influence their activity by altering their gating properties or their interaction with the lipid bilayer of the cell membrane. Inhibitors of STOML3 disrupt its ability to regulate these channels, potentially affecting how cells respond to mechanical stimuli.
The mechanism of action for STOML3 inhibitors typically involves binding to key domains of the STOML3 protein, preventing it from associating with ion channels or the cell membrane. By inhibiting STOML3's function, these compounds can reduce or alter the mechanosensitivity of ion channels, disrupting normal mechanotransduction pathways. Some inhibitors may act by inducing conformational changes in STOML3, rendering it unable to modulate the gating or activity of mechanosensitive channels. This inhibition affects the transmission of mechanical signals in cells, particularly in sensory neurons, which depend on these pathways to detect and respond to touch, pressure, and other physical stimuli. Research into STOML3 inhibitors provides insights into the molecular mechanisms underlying mechanosensation and highlights the critical role that STOML3 plays in fine-tuning ion channel function. Understanding how STOML3 regulates mechanotransduction contributes to a broader understanding of sensory biology and the intricate cellular processes involved in detecting and responding to mechanical forces.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Can inhibit various ion channels, potentially influencing the activity mediated by STOML3. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
L-type calcium channel blocker that can indirectly affect STOML3 associated processes. | ||||||
Gadolinium | 7440-54-2 | sc-250038 | 10 g | $89.00 | ||
Acts as an inhibitor of stretch-activated ion channels, thereby influencing STOML3. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Known to inhibit certain ion channels and can indirectly impact STOML3 functions. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
L-type calcium channel blocker with potential to modulate STOML3 associated processes. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Another calcium channel blocker with potential indirect effects on STOML3. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Can modulate activity of certain ion channels, indirectly affecting STOML3. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Known to block certain ion channels, potentially affecting processes modulated by STOML3. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
Inhibits receptor-operated calcium channels, which can influence STOML3 pathways. | ||||||